NeuroSense Therapeutics Ltd. NRSN
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.09% | -44.87% | 27.95% | ||
| Total Receivables | -79.88% | 125.27% | -30.51% | ||
| Inventory | -38.75% | -- | -- | ||
| Prepaid Expenses | -8.05% | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 34.29% | 22.86% | -12.50% | ||
| Total Current Assets | -82.33% | -3.89% | 50.96% | ||
|
|
|||||
| Total Current Assets | -82.33% | -3.89% | 50.96% | ||
| Net Property, Plant & Equipment | 52.00% | -47.50% | -39.27% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -4.35% | 4.55% | 4.55% | ||
| Total Assets | -77.53% | -8.53% | 43.64% | ||
|
|
|||||
| Total Accounts Payable | -31.12% | -26.30% | -20.49% | ||
| Total Accrued Expenses | 113.31% | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 34.25% | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | -45.19% | -- | ||
| Total Other Current Liabilities | -- | -45.19% | -- | ||
| Total Current Liabilities | 26.31% | -37.20% | -42.41% | ||
|
|
|||||
| Total Current Liabilities | 26.31% | -37.20% | -42.41% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 29.92% | -37.84% | -59.71% | ||
|
|
|||||
| Common Stock & APIC | 17.79% | 33.15% | 61.08% | ||
| Retained Earnings | -30.35% | -27.75% | -40.35% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -160.39% | 69.52% | 246.84% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -160.39% | 69.52% | 246.84% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -160.39% | 69.52% | 246.84% | ||
|
|
|||||